COMPARISON OF TWO THERAPEUTIC STRATEGIES FOR TREATING TYPE 2 DIABETIC PATIENTS POORLY CONTROLLED WITH BASAL INSULIN ASSOCIATED WITH ORAL ANTIDIABETIC DRUGS: 6-MONTH PROOF OF CONCEPT STUDY

Registry ID
EUCTR2005-002614-38
Source registry
EUCTR
Status
Completed
Phase
PHASE4
Sponsor
SANOFI AVENTIS GROUPE
Start date
2006-09-07
Completion date
2008-08-20
Last update
2026-08-16

Conditions

Summary

The primary objective of the study is to evaluate the efficacy (measured by the percentage of patients achieving an Hemoglobin A1c (HbA1c) level at the end of treatment period < 7%) of a single injection of glulisine before the main meal added to insulin glargine plus oral antidiabetic drugs (OADs) compared to insulin glargine plus OADs in Type 2 diabetic patients poorly controlled with basal insulin plus OADs.

Locations

View on source registry